MLKL and infection: In addition, neutralizing antibody to IL-1β reduced the cell viability of N2aC24L1-3 cells in a dose-dependent manner (Fig. 3D) and increased phosphorylated MLKL in N2aC24L1-3 cells after IAV/WSN infection (Fig. 3E).